Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay
NCT02912117 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 57
Last updated 2018-05-11
Summary
Prospective, observational study at Stanford University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to the Final Microbiologic Diagnosis in Patients with Fever and Neutropenia.
Conditions
Sponsors & Collaborators
- collaborator OTHER
-
Karius, Inc.
lead INDUSTRY
Principal Investigators
-
Stanley C Deresinski, MD · Stanford University
-
Jose G Montoya, MD · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-31
- Primary Completion
- 2018-02-28
- Completion
- 2018-05-31
Countries
- United States
Study Locations
More Related Trials
-
Early Antibiotic Discontinuation in FUO
NCT02906254 ·Status: COMPLETED
-
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca
NCT04662892 ·Status: UNKNOWN
-
Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
NCT07204522 ·Status: RECRUITING
-
Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia
NCT02816112 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates
NCT06908616 ·Status: RECRUITING
-
Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias
NCT01144793 ·Status: COMPLETED
-
Fever and Neutropenia in Pediatric Oncology Patients
NCT03768869 ·Status: WITHDRAWN ·Phase: PHASE3
-
Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
NCT00945555 ·Status: COMPLETED
-
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
NCT00883181 ·Status: COMPLETED
-
Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein
NCT02465801 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers
NCT06698861 ·Status: COMPLETED ·Phase: PHASE1
-
Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy
NCT01799421 ·Status: COMPLETED
-
iDTECT Blood Performance for the Identification of Viral or Bacterial Pathogens in Febrile Neutropenic Patients
NCT03364257 ·Status: UNKNOWN
-
Registry of Febrile Neutropenia and Invasive Fungal Infections
NCT01684189 ·Status: UNKNOWN
-
Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
NCT07277387 ·Status: NOT_YET_RECRUITING
-
PEG-rhG-CSF in Patients With Breast Cancer Receiving Chemotherapy to Prevent Neutropenia
NCT02805205 ·Status: COMPLETED ·Phase: PHASE4
-
Fatigue and Symptom Burden in Low-Risk Cancer Patients Undergoing Treatment for Febrile Neutropenia
NCT00503854 ·Status: COMPLETED
-
Short Antibiotic Treatment in High Risk Febrile Neutropenia
NCT05786495 ·Status: RECRUITING ·Phase: NA
-
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
NCT01813721 ·Status: COMPLETED
-
Profiling Neutrophil Counts in Patients on Chemotherapy
NCT02806557 ·Status: UNKNOWN
-
PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia
NCT02996617 ·Status: UNKNOWN ·Phase: PHASE4
-
Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy
NCT07113314 ·Status: COMPLETED ·Phase: NA
-
A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers
NCT02205320 ·Status: UNKNOWN ·Phase: PHASE1
-
Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients
NCT03246009 ·Status: COMPLETED ·Phase: PHASE1
-
Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients
NCT03968328 ·Status: COMPLETED